Accelerating Outcomes with a Pancreatic Cancer Adaptive Platform

Case study

 
Home / Clinical Technologies /

When the Pancreatic Cancer Action Network© were launching an important master protocol trial designed to accelerate outcomes in a cancer with a less than 10% survival rate, they were presented with a challenge:

How do you set up an IRT system for a perpetual design to account for seamless introduction of new investigational treatments? 

When your goal is to identify effective and ineffective treatments more quickly than traditional trials through a Complex Innovative Design, the right IRT system is crucial.

In this case study, we discuss:

  • How a Complex Innovative Design is used to evaluate multiple treatments in multiple patient populations and why leveraging a flexible IRT is key
  • Why early and frequent collaboration amongst key players drives successful implementation of the IRT for Complex Innovative Designs.
  • How IRT systems can be built to accommodate future unknowns.
  • Leveraging a Bayesian Response-Adaptive Randomization (BRAR) algorithm to “learn as you go” and how the IRT dynamically responds to changing probabilities.
This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies